Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
CBD and Cannabis Products in Pets With Cancer: Regulatory and Safety Boundary
FDA has not approved CBD for animal use, and product quality, THC contamination, interactions, liver effects, sedation, legal status, and cancer claims require caution.
Read moreChinese Herbal Formulas: Identification, Quality, and Evidence Review
A named traditional formula can vary by translation, ingredient, species, processing, manufacturer, and practitioner modification, so exact identification comes before benefit or safety claims.
Read more
Yunnan Baiyao-Type Hemostasis Discussion: Preclinical Evidence Is Not Bleeding Control
Yunnan Baiyao is used anecdotally in veterinary bleeding plans, but formulation opacity and limited clinical evidence do not support relying on it to prevent or stop tumor hemorrhage.
Read moreProbiotics and Synbiotics During Cancer Treatment: Strain-Specific Evidence
Probiotic effects are strain-, combination-, product-, storage-, and condition-specific, and immune compromise changes the safety conversation.
Read more
Veterinary Acupuncture in Cancer Support: Symptom-Focused Evidence Boundary
Acupuncture may be discussed as an adjunct for selected pain, nausea, mobility, or wellbeing goals, but veterinary oncology-specific clinical evidence is limited.
Read more
Treatment Goals, Time, Cost, and Contingency Planning
A useful oncology plan makes the intended goal, expected care burden, financial boundaries, decision checkpoints, and backup options explicit without treating cost or caregiver limits as a failure.
Read more
Named profile Bedinvetmab (Librela): Canine Osteoarthritis Pain Support in OncologyRepresentative category illustration – no product packaging is shown.Bedinvetmab (Librela): Canine Osteoarthritis Pain Support in Oncology
bedinvetmab is covered as canine monoclonal-antibody analgesic for osteoarthritis pain; not an antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Frunevetmab (Solensia): Feline Osteoarthritis Pain Support in OncologyRepresentative category illustration – no product packaging is shown.Frunevetmab (Solensia): Feline Osteoarthritis Pain Support in Oncology
frunevetmab is covered as feline monoclonal-antibody analgesic for osteoarthritis pain; not an antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more